US pharma organizations work together to foster supply chain security and integrity
The 100th meeting of the USA-based National Conference of Pharmaceutical Organizations (NCPO) – consisting of US pharma, biotech and generic trade groups, as well as pharmacy and other health care groups - resolved that the member organizations will work together to help further secure the pharmaceutical supply chain.
“Supply chain issues go to the very safety of the medicines that all Americans rely on for the health of their families,” said John Castellani, president and chief executive of the Pharmaceutical Research and Manufacturers of America (PhRMA) and chairman of the NCPO meeting, adding: “It is our responsibility to do everything we can together so that patients and their families know that the medicines they take are safe.”
The NCPO discussions on pharmaceutical supply chain security centered around three areas: product tracing, Internet sales, and disposal of unused medicines. The NCPO organizations agreed to key principles in each area.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Biotechnology
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze